HealthVerity has announced plans to acquire Symphony Health, a commercial healthcare data and analytics company currently owned by ICON plc, in a move to unify real-world clinical data with commercial intelligence. The transaction, expected to close within the month, will consolidate the companies’ capabilities into a single platform designed to serve life sciences organizations, payers, and government entities.
HealthVerity is recognized for its data exchange and patient identity platform, which enables users to identify patient populations for research, link datasets, and generate insights from real-world data. Symphony Health complements this with a broad portfolio that includes data aggregation, consulting services, market intelligence tools, and support for health economics and outcomes research (HEOR).
By combining these assets, the merged platform aims to provide a more comprehensive view of patient journeys and healthcare dynamics, bridging gaps between clinical outcomes and commercial performance. The integration is expected to strengthen data-driven decision-making across research, development, and commercialization functions.
Andrew Kress, CEO of HealthVerity, said, "This transaction will create the nation's leading patient-centric real-world and commercial data ecosystem within a privacy-safe, modern infrastructure. This will allow us to rapidly innovate in developing the next generation of real-world data and applications, giving organizations across the healthcare ecosystem more dynamic and actionable insights to make better and faster decisions."
Symphony Health has evolved through a series of acquisitions since its founding in 2012. It was acquired by PRA Health Sciences in 2017 for $530 million, before becoming part of ICON in 2021 following PRA’s acquisition. Within ICON, Symphony Health has operated as a subsidiary supporting clinical development and commercialization services for pharmaceutical, biotechnology, and medical device companies.
HealthVerity, in contrast, has scaled through venture-backed growth, raising multiple funding rounds over the past decade:
$7.1 million Series A in 2016
$10 million Series B in 2017
$25 million Series C in 2019
$100 million Series D in 2021
The acquisition reflects broader consolidation trends in healthcare data and analytics, as organizations seek integrated platforms capable of delivering more actionable and privacy-compliant insights across the healthcare ecosystem.
Click here for the original news story.
